Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Virgin Galactic Holdings, Inc. — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Virgin Galactic Holdings, Inc. trades at $2.84 (market cap $445.69M). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 13.6× Virgin Galactic Holdings, Inc.'s market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Virgin Galactic Holdings, Inc. for 69 Days on average.
| IOVA | SPCE | |
|---|---|---|
Market Cap | $6.04B | $445.69M |
Volume | 14,805,993 | 5,128,850 |
Sector | Health | Industrials |
52-Week High | $14.82 | $7.52 |
52-Week Low | $1.81 | $2.17 |
Typical Hold Time | 0 Days | 69 Days |
Enterprise Value | $5.97B | $409.68M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Virgin Galactic (SPCE) trades at $2.94, down 2.33% with a bearish technical signal. The company continues to report significant losses with negative gross and net income margins, though recent quarters have shown smaller-than-expected losses. Cash flow remains negative despite improving trends, with management targeting positive quarterly cash flow by 2027. Analyst sentiment is divided with a slight lean toward Hold.
The outlook remains speculative with high execution risk. While space tourism offers long-term potential, ongoing losses, debt burden, and delayed commercial flights create substantial headwinds. The stock presents a high-risk opportunity for investors betting on successful commercialization, but requires careful risk management given the company's financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
